Similarly, genomic aberrations in the SWI-SNF chromatin remodeling complex, mutations in SMARCA4 and ARID2 and recurrent copy number deletions in SMARCA2 confers intrinsic resistance to venetoclax in relapsed/refractory MCL as a result of BCL-xL overexpression. The gene discussed is SMARCA4; the disease is mantle cell lymphoma.